Pnd32 - Cost Comparison of Multiple Sclerosis First Line Treatment With Available Interferons Within the Brazilian Public Healthcare System

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1999
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search